Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Psyence Group Inc C.PSYG

Alternate Symbol(s):  PSYGF

Healthcare Biotechnology Drug Manufacturers - Major
Psyence Group Inc. is a Canada-based life science biotechnology company with a focus on natural psychedelics. The Company is focused on the research, cultivation and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness. It cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at its federally licensed ISO22000 facility in Southern Africa. The Company’s divisions include Psyence Production, Psyence Therapeutics and Psyence Function. Psyence Therapeutics develops natural psilocybin products, medicinal formulations and treatment protocols to treat mental health disorders in a clinical environment. Psyence Production operates federally licensed ISO22000 certified psilocybin cultivation and production facilities in the world. Psyence Function is focused on the development, distribution and sale of over-the-counter functional mushroom nutraceutical products.


CSE:PSYG - Post by User

Psyence Group Inc > Commencement of Online Sales and Distribution of “GOODMIND”
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by skydiver069on Jun 21, 2022 4:54pm
232 Views
Post# 34772339

RE:Commencement of Online Sales and Distribution of “GOODMIND”

RE:Commencement of Online Sales and Distribution of “GOODMIND” So, the company continues indepth testing in Africa for another couple of months, then releases for Western online sales if medical complaints do not exceed expected values.  Correct?

“We are delighted that our first nutraceutical product, GOODMIND™, is now available for sale online in South Africa."

https://foragoodmind.com/

Either way, after reviewing the website, some of the varieties have caught my attention and thus I would consider testing them out.  As many of us will desire, hopefully there would be no chemical collisions with pharmaceutical medicines.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities